{"count": 23, "results": [{"_id": "37304386", "pmid": 37304386, "pmcid": "PMC10250023", "title": "A Fatal Case of Lisinopril-Induced Acute Necrotizing Pancreatitis", "journal": "Cureus", "authors": ["Masarweh OM", "Al-Moussally F", "Meruvia Garron JP", "Kunadia A", "Karasik O", "Asmar A"], "date": "2023-06-07T00:00:00Z", "doi": "10.7759/cureus.40071", "meta_date_publication": "2023 Jun", "meta_volume": "15", "meta_issue": "6", "meta_pages": "e40071", "score": 50266.348, "text_hl": "Angiotensin-converting enzyme inhibitors (ACE-I), such as @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, are used as first-line therapy in the treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ with reduced ejection fraction, and @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@proteinuric chronic kidney disease@@@ due to their beneficial effects on reducing morbidity and mortality. ", "citations": {"NLM": "Masarweh OM, Al-Moussally F, Meruvia Garron JP, Kunadia A, Karasik O, Asmar A. A Fatal Case of Lisinopril-Induced Acute Necrotizing Pancreatitis Cureus. 2023 Jun;15(6):e40071. PMID: 37304386", "BibTeX": "@article{37304386, title={A Fatal Case of Lisinopril-Induced Acute Necrotizing Pancreatitis}, author={Masarweh OM and Al-Moussally F and Meruvia Garron JP and Kunadia A and Karasik O and Asmar A}, journal={Cureus}, volume={15}, number={6}, pages={e40071}}"}}, {"_id": "39466390", "pmid": 39466390, "title": "Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management: a 10-year cohort study.", "journal": "Pediatr Nephrol", "authors": ["Degraeuwe E", "Gasthuys E", "Snauwaert E", "Dossche L", "Prytula A", "Dehoorne J", "Vermeulen A", "Walle JV", "Raes A"], "date": "2024-10-28T00:00:00Z", "doi": "10.1007/s00467-024-06531-1", "meta_date_publication": "2024 Oct 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50264.69, "text_hl": "METHODS: This is a retrospective cohort study at Ghent University Hospital, Belgium, with 106 young @SPECIES_9606 @@@patients@@@ (1-18 years) treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ due to @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (@DISEASE_Hypertension @DISEASE_MESH:D006973 @@@HTN@@@) and @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ (@<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@) assessed for treatment outcomes against clinical benchmarks over 10 years. ", "citations": {"NLM": "Degraeuwe E, Gasthuys E, Snauwaert E, Dossche L, Prytula A, Dehoorne J, Vermeulen A, Walle JV, Raes A. Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management: a 10-year cohort study. Pediatr Nephrol. 2024 Oct 28;():. PMID: 39466390", "BibTeX": "@article{39466390, title={Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management: a 10-year cohort study.}, author={Degraeuwe E and Gasthuys E and Snauwaert E and Dossche L and Prytula A and Dehoorne J and Vermeulen A and Walle JV and Raes A}, journal={Pediatr Nephrol}}"}}, {"_id": "37303355", "pmid": 37303355, "pmcid": "PMC10257359", "title": "Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge", "journal": "Cureus", "authors": ["Milki AA", "Bechara M", "Lew SQ", "Poon AN"], "date": "2023-05-11T00:00:00Z", "doi": "10.7759/cureus.38876", "meta_date_publication": "2023 May", "meta_volume": "15", "meta_issue": "5", "meta_pages": "e38876", "score": 50262.27, "text_hl": "The @SPECIES_9606 @@@patient@@@ was prescribed @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ at the time of diagnosis. ", "citations": {"NLM": "Milki AA, Bechara M, Lew SQ, Poon AN. Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge Cureus. 2023 May;15(5):e38876. PMID: 37303355", "BibTeX": "@article{37303355, title={Chronic Kidney Disease of Non-traditional Etiology in a Young Man From Central America: Geography, Poverty, and Uncertain Pathophysiology Create a Formidable Medical Challenge}, author={Milki AA and Bechara M and Lew SQ and Poon AN}, journal={Cureus}, volume={15}, number={5}, pages={e38876}}"}}, {"_id": "36300543", "pmid": 36300543, "title": "The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.", "journal": "Fundam Clin Pharmacol", "authors": ["Abdelrahman AM", "Ali BH", "Ali H", "Manoj P", "Al-Suleimani Y"], "date": "2022-10-27T00:00:00Z", "doi": "10.1111/fcp.12845", "meta_date_publication": "2022 Oct 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.934, "text_hl": "The present study investigated the effect of @CHEMICAL_Diminazene @CHEMICAL_MESH:D004133 @@@diminazene@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, or @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ on @CHEMICAL_Adenine @CHEMICAL_MESH:D000225 @@@adenine@@@-induced @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ (@<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@) in @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Abdelrahman AM, Ali BH, Ali H, Manoj P, Al-Suleimani Y. The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats. Fundam Clin Pharmacol. 2022 Oct 27;():. PMID: 36300543", "BibTeX": "@article{36300543, title={The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.}, author={Abdelrahman AM and Ali BH and Ali H and Manoj P and Al-Suleimani Y}, journal={Fundam Clin Pharmacol}}"}}, {"_id": "36472269", "pmid": 36472269, "title": "EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.", "journal": "Wiad Lek", "authors": ["Babinets LS", "Levchuk RD", "Halabitska IM", "Kryskiv OI"], "date": "2022-01-01T00:00:00Z", "doi": "10.36740/WLek202210116", "meta_date_publication": "2022", "meta_volume": "75", "meta_issue": "10", "meta_pages": "2407-2411", "score": 50248.74, "text_hl": "For antihypertensive therapy, the most common drugs for use were selected - @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ + amplodipine in fixed doses of 10 and 5 mg, respectively. ", "citations": {"NLM": "Babinets LS, Levchuk RD, Halabitska IM, Kryskiv OI. EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE. Wiad Lek. 2022;75(10):2407-2411. PMID: 36472269", "BibTeX": "@article{36472269, title={EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.}, author={Babinets LS and Levchuk RD and Halabitska IM and Kryskiv OI}, journal={Wiad Lek}, volume={75}, number={10}, pages={2407-2411}}"}}, {"_id": "20112435", "pmid": 20112435, "title": "Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.", "journal": "Pharmacoepidemiol Drug Saf", "authors": ["Johnson ES", "Weinstein JR", "Thorp ML", "Platt RW", "Petrik AF", "Yang X", "Anderson S", "Smith DH"], "date": "2010-03-01T00:00:00Z", "doi": "10.1002/pds.1923", "meta_date_publication": "2010 Mar", "meta_volume": "19", "meta_issue": "3", "meta_pages": "266-72", "score": 50071.52, "text_hl": "Predicting the risk of @DISEASE_Hyperkalemia @DISEASE_MESH:D006947 @@@hyperkalemia@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ starting @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@.", "citations": {"NLM": "Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, Anderson S, Smith DH. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):266-72. PMID: 20112435", "BibTeX": "@article{20112435, title={Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.}, author={Johnson ES and Weinstein JR and Thorp ML and Platt RW and Petrik AF and Yang X and Anderson S and Smith DH}, journal={Pharmacoepidemiol Drug Saf}, volume={19}, number={3}, pages={266-72}}"}}, {"_id": "28445490", "pmid": 28445490, "pmcid": "PMC5405968", "title": "The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon", "journal": "PLoS One", "authors": ["Ali BH", "Karaca T", "Al Suleimani Y", "Al Za'abi M", "Al Kalbani J", "Ashique M", "Nemmar A"], "date": "2017-04-26T00:00:00Z", "doi": "10.1371/journal.pone.0176316", "meta_date_publication": "2017", "meta_volume": "12", "meta_issue": "4", "meta_pages": "e0176316", "score": 50062.637, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ is commonly used in the management of @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ in @SPECIES_9606 @@@humans@@@.", "citations": {"NLM": "Ali BH, Karaca T, Al Suleimani Y, Al Za'abi M, Al Kalbani J, Ashique M, Nemmar A. The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon PLoS One. 2017;12(4):e0176316. PMID: 28445490", "BibTeX": "@article{28445490, title={The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon}, author={Ali BH and Karaca T and Al Suleimani Y and Al Za'abi M and Al Kalbani J and Ashique M and Nemmar A}, journal={PLoS One}, volume={12}, number={4}, pages={e0176316}}"}}, {"_id": "21516765", "pmid": 21516765, "title": "[Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure].", "journal": "Klin Med (Mosk)", "authors": ["Tofan EF", "Butorov IV", "Gonchar VI", "Nekula GI"], "date": "2011-01-01T00:00:00Z", "meta_date_publication": "2011", "meta_volume": "89", "meta_issue": "1", "meta_pages": "40-4", "score": 50062.613, "text_hl": "Combined treatment produced more significant improvement of @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CHI@@@ symptoms than monotherapy with either drug. ", "citations": {"NLM": "Tofan EF, Butorov IV, Gonchar VI, Nekula GI. [Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure]. Klin Med (Mosk). 2011;89(1):40-4. PMID: 21516765", "BibTeX": "@article{21516765, title={[Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure].}, author={Tofan EF and Butorov IV and Gonchar VI and Nekula GI}, journal={Klin Med (Mosk)}, volume={89}, number={1}, pages={40-4}}"}}, {"_id": "19952417", "pmid": 19952417, "title": "Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats.", "journal": "Biol Pharm Bull", "authors": ["Tsujimura T", "Nagamine J", "Sugaru E", "Ono-Kishino M", "Tokunaga T", "Kitoh M", "Nagata R", "Nakagawa T", "Taiji M"], "date": "2009-12-01T00:00:00Z", "doi": "10.1248/bpb.32.1991", "meta_date_publication": "2009 Dec", "meta_volume": "32", "meta_issue": "12", "meta_pages": "1991-6", "score": 50062.285, "text_hl": "The number of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ (@<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@) has continuously grown worldwide. ", "citations": {"NLM": "Tsujimura T, Nagamine J, Sugaru E, Ono-Kishino M, Tokunaga T, Kitoh M, Nagata R, Nakagawa T, Taiji M. Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats. Biol Pharm Bull. 2009 Dec;32(12):1991-6. PMID: 19952417", "BibTeX": "@article{19952417, title={Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats.}, author={Tsujimura T and Nagamine J and Sugaru E and Ono-Kishino M and Tokunaga T and Kitoh M and Nagata R and Nakagawa T and Taiji M}, journal={Biol Pharm Bull}, volume={32}, number={12}, pages={1991-6}}"}}, {"_id": "10606834", "pmid": 10606834, "title": "Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.", "journal": "Br J Clin Pharmacol", "authors": ["Greenbaum R", "Zucchelli P", "Caspi A", "Nouriel H", "Paz R", "Sclarovsky S", "O'Grady P", "Yee KF", "Liao WC", "Mangold B"], "date": "2000-01-01T00:00:00Z", "doi": "10.1046/j.1365-2125.2000.00103.x", "meta_date_publication": "2000 Jan", "meta_volume": "49", "meta_issue": "1", "meta_pages": "23-31", "score": 50060.547, "text_hl": "Comparison of the pharmacokinetics of @CHEMICAL_fosinoprilat @CHEMICAL_MESH:C046965 @@@fosinoprilat@@@ with @CHEMICAL_Enalaprilat @CHEMICAL_MESH:D015773 @@@enalaprilat@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@congestive heart failure@@@ and @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic renal insufficiency@@@.", "citations": {"NLM": "Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, O'Grady P, Yee KF, Liao WC, Mangold B. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. Br J Clin Pharmacol. 2000 Jan;49(1):23-31. PMID: 10606834", "BibTeX": "@article{10606834, title={Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.}, author={Greenbaum R and Zucchelli P and Caspi A and Nouriel H and Paz R and Sclarovsky S and O'Grady P and Yee KF and Liao WC and Mangold B}, journal={Br J Clin Pharmacol}, volume={49}, number={1}, pages={23-31}}"}}]}